Holen Sie sich die Stockscreener-App
3.06
1.61%
-0.05
Schlusskurs vom Vortag:
$3.11
Offen:
$3.11
24-Stunden-Volumen:
2.74M
Relative Volume:
0.73
Marktkapitalisierung:
$708.26M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-179.82M
KGV:
-2.3008
EPS:
-1.33
Netto-Cashflow:
$-159.16M
1W Leistung:
+12.92%
1M Leistung:
+40.37%
6M Leistung:
+166.09%
1J Leistung:
+360.43%
1-Tages-Spanne:
$2.93
$3.17
1-Wochen-Bereich:
$2.654
$3.275
52-Wochen-Spanne:
$0.6666
$3.60
Gossamer Bio Inc Stock (GOSS) Company Profile
Firmenname
Gossamer Bio Inc
Sektor
Branche
Telefon
(858) 684-1300
Adresse
3115 MERRYFIELD ROW, SAN DIEGO, CA
Vergleichen Sie GOSS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GOSS
Gossamer Bio Inc
|
3.06 | 719.83M | 0 | -179.82M | -159.16M | -1.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Gossamer Bio Inc Stock (GOSS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-10 | Hochstufung | UBS | Neutral → Buy |
| 2025-07-14 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-06-25 | Eingeleitet | Oppenheimer | Outperform |
| 2024-04-05 | Fortgesetzt | Wedbush | Outperform |
| 2023-07-27 | Herabstufung | UBS | Buy → Neutral |
| 2023-03-07 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-03-01 | Eingeleitet | Guggenheim | Neutral |
| 2022-12-07 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-12-07 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2022-12-07 | Herabstufung | SMBC Nikko | Outperform → Neutral |
| 2022-10-20 | Eingeleitet | Goldman | Buy |
| 2022-09-21 | Eingeleitet | JP Morgan | Neutral |
| 2022-09-19 | Eingeleitet | Wedbush | Outperform |
| 2022-04-18 | Eingeleitet | Raymond James | Outperform |
| 2022-04-06 | Eingeleitet | UBS | Buy |
| 2022-01-10 | Hochstufung | SMBC Nikko | Neutral → Outperform |
| 2021-11-09 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2021-09-21 | Fortgesetzt | Piper Sandler | Overweight |
| 2020-06-29 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-04-22 | Eingeleitet | Piper Sandler | Overweight |
| 2020-02-27 | Eingeleitet | Barclays | Overweight |
| 2019-12-03 | Fortgesetzt | BofA/Merrill | Buy |
| 2019-10-30 | Eingeleitet | Berenberg | Buy |
| 2019-03-05 | Eingeleitet | Barclays | Overweight |
| 2019-03-05 | Eingeleitet | BofA/Merrill | Buy |
| 2019-03-05 | Eingeleitet | Evercore ISI | Outperform |
| 2019-03-05 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Gossamer Bio Inc Aktie (GOSS) Neueste Nachrichten
How Gossamer Bio Inc. (4GB) stock reacts to fiscal policiesWeekly Trend Summary & Consistent Growth Equity Picks - newser.com
How Gossamer Bio Inc. (4GB) stock moves in volatile trading sessionsMarket Risk Analysis & Stock Portfolio Risk Management - newser.com
What downside risks could hit Gossamer Bio Inc. (4GB) stock2025 Winners & Losers & Detailed Earnings Play Strategies - newser.com
Volume spikes in Gossamer Bio Inc. stock – what they meanPortfolio Risk Summary & Accurate Trade Setup Notifications - newser.com
What RSI levels show for Gossamer Bio Inc. (4GB) stockPortfolio Gains Report & Fast Entry Momentum Trade Alerts - newser.com
Strategies to average down on Gossamer Bio Inc.2025 Trading Recap & Long Hold Capital Preservation Tips - newser.com
Will Gossamer Bio Inc. stock benefit from sector rotationJuly 2025 Short Interest & Low Risk High Reward Ideas - newser.com
Why Gossamer Bio Inc. (4GB) stock could outperform next yearMarket Sentiment Report & Entry Point Confirmation Alerts - newser.com
Is now a turning point for Gossamer Bio Inc.July 2025 Market Mood & Real-Time Stock Movement Alerts - newser.com
Is Gossamer Bio Inc. stock near bottom after declineJuly 2025 Pullbacks & Safe Entry Point Identification - newser.com
Ranking Gossamer Bio Inc. among high performing stocks via toolsQuarterly Market Summary & High Accuracy Swing Entry Alerts - newser.com
Why retail investors favor Gossamer Bio Inc. stockTreasury Yields & Advanced Swing Trade Entry Alerts - newser.com
Why Gossamer Bio Inc. stock remains undervalued2025 Risk Factors & Reliable Momentum Entry Alerts - newser.com
Why millennials buy Gossamer Bio Inc. (4GB) stockMarket Activity Recap & Community Verified Watchlist Alerts - newser.com
What valuation multiples suggest for Gossamer Bio Inc. stockBuy Signal & Community Verified Watchlist Alerts - newser.com
How to use Fibonacci retracement on Gossamer Bio Inc.Market Growth Summary & Real-Time Sentiment Analysis - newser.com
What Wall Street predicts for Gossamer Bio Inc. stock priceEarnings Growth Summary & Free Verified High Yield Trade Plans - newser.com
What Fibonacci levels say about Gossamer Bio Inc. reboundJuly 2025 Reactions & Verified Stock Trade Ideas - newser.com
Finanzdaten der Gossamer Bio Inc-Aktie (GOSS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.38%
1.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):